PA005286-ANT-135: CD11a (LFA-1) Monoclonal Antibody
Rat Monoclonal Antibody;
Reactivity: Mouse;
Clone: mCD11a;
Isotype: Rat IgG2b.C045P: Efalizumab Biosimilar, CD11a Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade efalizumab biosimilar specifically binds to the human CD11a.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by efalizumab.PA006533-PA1787: HEXA Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, IHC-P;
Reactivity: Humsn, Rat, Mouse.BP000245-CYT-242: Recombinant Human PDGF BB, Yeast
Source: Saccharomyces cerevisiae-derived.
The ED50, calculated by the dose-dependant proliferation of BALB/c 3T3 indicator cells (measured by 3H-thymidine uptake) is < 1 ug/ml, corresponding to a Specific Activity of 1 MIU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000245-CYT-412: Recombinant Mouse PDGF BB
Source: E. coli-derived.
The biological activity is determined by the dose-dependant stimulation of the proliferation of human umbelical vein endothelial cells (HUVEC) using a concentration range of less than 1.6 ug/ml.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000245-CYT-501: Recombinant Human PDGF BB
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells. The expected ED50 for this effect is 1.0-3.0 ug/ml.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000244-C199: Recombinant Human Platelet-Derived Growth Factor Subunit B (PDGFB) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000244-CYT-492: Recombinant Human Platelet-Derived Growth Factor Subunit B (PDGFB) Protein
Source: E. coli-derived.
A non-glycosylated, polypeptide chain containing 109 amino acids fragment (82-190) and having a molecular mass of 16.75 kDa.
Purity: > 95% by SDS-PAGE.